This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cosmetic dermatologists must learn to harness technology while upholding the core values of safety, ethics, and patient satisfaction, writes Neelam Vashi, MD, an Associate Professor of Dermatology at Boston University Chobanian & Avedisian School of Medicine in Boston, MA, in the Journal of Clinical Medicine.
After releasing promising data from several clinical trials, Burnett discussed the importance of studying efficacy and safety across diverse populations.
Deucravacitinib (Sotyktu, Bristol Myers Squibb) showed consistent safety and efficacy in patients with in moderate-to-severe plaque psoriasis for up to five years, new research shows. Moreover, the safety profile of deucravacitinib remained consistent through five years with no new safety signals identified.
No safety signals emerged through Week 24. “It’s an oral drug that will rival biologics in efficacy,” says study author Jennifer Soung, MD, a Dermatologist and Director of Clinical Research at Southern California Dermatology in Los Angeles, CA.
The clinical results demonstrated that STEQEYMA and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of safety and efficacy. “STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb).
Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Th e Phase 3b, randomized, double-blind, placebo-controlled clinical trial included 99 patients with moderate-to-severe plaque psoriasis. ” The safety profile was consistent with the known safety profile of tildrakizumab, and no serious adverse events related to ILUMYA treatment occurred in this clinical trial,the study showed. .
The Phase 3 TRuE-PN clinical trial program comprises TRuE-PN1 and TRuE-PN2 studies, which evaluate the safety and efficacy of twice-daily ruxolitinib cream 1.5% All you need is chronic itch for six weeks or longer, nodules, pustules, excoriation, and scratching; You dont need a biopsy as that can confuse the clinical picture.
While botulinum toxin has emerged as a treatment course for rosacea in recent years, researchers are calling for more comprehensive and detailed long-term research to assess its effectiveness.
This foundational knowledge is critical for practitioners who wish to perform aesthetic procedures with precision, confidence, and a commitment to patient safety. Our facial aesthetics program provides a detailed understanding of facial anatomy, physiognomy, and essential techniques, such as Botox and dermal filler injections.
This announcement follows the successful completion of a Phase I clinical trial involving 40 healthy volunteers, where ruxoprubart demonstrated promising results and a clean safety profile, with no serious adverse events reported. Robert Bard, VP of Regulatory Affairs at NovelMed Therapeutics. The post U.S.
topical ET-02 may be more effective than existing treatments for androgenic alopecia, according to results of a first-in-man clinical trial. In a double-blind, placebo-controlled, dose-ranging clinical study of 24 subjects at three U.S. In a double-blind, placebo-controlled, dose-ranging clinical study of 24 subjects at three U.S.
AK006 disappointed in a Phase 1 study of chronic spontaneous urticaria (CSU), and the Company will discontinue further clinical development of AK006. The primary endpoint of the proof-of-concept cohort was safety and tolerability with therapeutic activity explored using the Urticaria Activity Score (UAS)-7 at 14 weeks. Allakos Inc.s
In this blog, well build upon our discussion of licensure versus certification and explore the different classifications of certifications in esthetics and cosmetology, including Clinical Aesthetics and Master Clinical Aesthetics. Clinical Aesthetics Certification Who is this for? What Are Certifications? Want more info?
From futuristic at-home devices to clinics equipped with state-of-the-art machinery, technology has placed the tools for radiant skin in the hands of the many. The accessibility of tools and treatments prompts questions about their efficacy and safety, reminding us to trust professionals for guidance and comprehensive understanding.
Accrediting committees ensure that the quality and safety of your school is approved and noted by outside bodies. Atelier Esthetique has a clinic where our students can work for the general public. Thankfully, Atelier Esthetique Institute can help with our robust curriculum.
Restem’s ULSC therapy has shown promising results in early clinical trials, demonstrating safety, tolerability and initial clinically significant improvements, as well as the potential to significantly reduce the need for steroid use in patients.
Findings from 2 phase 3 trials indicate that ZORYVE cream significantly improves both clinical outcomes and quality of life in patients with mild to moderate atopic dermatitis.
Clinical studies indicate that saw palmetto can be an effective option for managing urinary symptoms during perimenopause and menopause, improving quality of life for many women. Urinary Tract Support As women age, they often experience urinary symptoms such as frequent urination, urgency, and discomfort.
The safety and efficacy of dupilumab in BP are currently under clinical investigation and have not been evaluated by any regulatory authority. Sustained disease remission was defined as complete clinical remission with completion of OCS taper by week 16 without relapse and no rescue therapy use during the 36-week treatment period.
Raj Chovatiya, MD, PhD, focused on understanding JAK inhibitors, discussing their clinical use and safety profiles for effective patient communication.
At Kim Gallo Esthetics, your comfort and safety is our top priority. It's hand-made here in the USA, FDA-cleared, and has been clinically proven to be effective. Microcurrent facials are considered to be very safe and can be used on all skin types.
The IGNITE study was a 24-week, randomized, placebo-controlled, double-blind study to assess the efficacy, safety and tolerability of rocatinlimab monotherapy every four weeks in 769 adults with moderate to severe AD, including patients previously treated with a biologic or systemic Janus kinase (JAK) inhibitor medication. At week 24, 22.7%
LP-310, developed by Lipella Pharmaceuticals for the treatment of oral lichen planus (OLP), is currently in Phase 2 clinical trials. Lipella has received an Investigational New Drug (IND) approval for a Phase 2a multicenter dose-escalation trial evaluating the safety and efficacy of LP-10 in subjects with symptomatic OLP.
a clinic) or at home. We are excited to be able to provide DEB patients with the first treatment that corrects the genetic defect and makes a true difference in their lives, says Cristina Has, MD, Professor and Head of the Genodermatoses Clinic in the Department of Dermatology at the University of Freiburg in Germany, in a news release.
For healthcare professionals seeking a fresh challenge , aesthetic medicine offers a perfect blend of clinical expertise, artistic precision, and patient care. Understanding patient safety protocols and treatment planning. Personal Fulfillment: Helping patients feel more confident in their appearance can be incredibly rewarding.
This FDA clearance was supported by AiVivas submission of safety data on non-facial skin tolerability and efficacy, and systemic exposure from 67 subjects treated with AIV001 in basal cell carcinoma and in scar management. To date, AiViva has completed three clinical studies using intradermal injection of AIV001.
The BLA submission for DMB-3115 is rooted in phase III multi-regional clinical trials focusing on plaque psoriasis patients. The results demonstrated a high similarity between DMB-3115 and ustekinumab in terms of quality, safety, and efficacy.
A panelist discusses how laser treatments demonstrate a strong safety profile and proven efficacy for patients with acne, with clinical studies showing significant reduction in both inflammatory and noninflammatory lesions.
The panelist discusses how safety data from clinical trials and real-world evidence should guide physicians in prescribing ruxolitinib cream, including patient monitoring protocols and managing potential adverse effects in atopic dermatitis treatment.
Dermatology Clinics. Microblading: Safety and Efficacy in Eyebrow Enhancement. Clinical and Aesthetic Dermatology. Journal of Cosmetic Dermatology. Shapiro, J., & Maddin, S. Hair Restoration Techniques and Outcomes. H., & Harcourt, D.
Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark where he plans to assist Clinical Professor of Dermatology Peter Bjerring MD, Dr.Sci., Department of Clinical Medicine at Aalborg University Hospital to build a new dermatological research area with collaboration with other specialities.
Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark where he plans to assist Clinical Professor of Dermatology Peter Bjerring MD, Dr.Sci., Department of Clinical Medicine at Aalborg University Hospital to build a new dermatological research area with collaboration with other specialities.
Preparing for Surgery Arrival at the Clinic Patients typically arrive at the clinic early in the morning, as Mohs surgery often takes several hours depending on how many stages are required. This initial step is essential for ensuring both patient safety and the precision of the procedure. How Long Does the Procedure Take?
SPECTREM is an ongoing Phase 3b, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of guselkumab in participants with low BSA (215%), moderate (Investigators Global Assessment [IGA]=3) plaque psoriasis involving 1 special sites (scalp, face, intertriginous, or genital).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content